Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns
The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approval for semaglutide injections. A diabetes patient raised concerns about the drug's delivery system, alleging it deviates from global standards and poses health risks. The court has directed the CDSCO to consider the patient's representation within two months.
Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata Motors
Indian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL, Tata Motors, and Bharti Airtel are in focus due to quarterly results and news developments. Zydus Lifesciences is nearing a US acquisition, while Maruti Suzuki commits to green logistics.
Zydus to launch CGM devices with AI-intelligence powered insights
Zydus Lifesciences announced its new offering companion diagnostics portfolio. The company will be launching Diasens and GlucoLive, next-generation Continuous Glucose Monitoring (CGM) devices that combine artificial intelligence powered insights, and integrated remote care capabilities. The CGM system is designed to monitor glucose with an integrated AI layer to provide analytics and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time.
Trade Spotlight: How should you trade AGI Infra, Zydus Lifesciences, Crompton Greaves, KIMS, Nazara Technologies, and others on May 18?
The market needs to deliver a sustainable close above the previous day's high for the upward journey. Below are some short-term trading ideas to consider.